Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
Gordon I. Smith, … , Marc K. Hellerstein, Samuel Klein
Gordon I. Smith, … , Marc K. Hellerstein, Samuel Klein
Published December 5, 2019
Citation Information: J Clin Invest. 2020;130(3):1453-1460. https://doi.org/10.1172/JCI134165.
View: Text | PDF
Clinical Research and Public Health Hepatology Metabolism Article has an altmetric score of 128

Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease

  • Text
  • PDF
Abstract

BACKGROUND An increase in intrahepatic triglyceride (IHTG) is the hallmark feature of nonalcoholic fatty liver disease (NAFLD) and is decreased by weight loss. Hepatic de novo lipogenesis (DNL) contributes to steatosis in individuals with NAFLD. The physiological factors that stimulate hepatic DNL and the effect of weight loss on hepatic DNL are not clear.METHODS Hepatic DNL, 24-hour integrated plasma insulin and glucose concentrations, and both liver and whole-body insulin sensitivity were determined in individuals who were lean (n = 14), obese with normal IHTG content (n = 26), or obese with NAFLD (n = 27). Hepatic DNL was assessed using the deuterated water method corrected for the potential confounding contribution of adipose tissue DNL. Liver and whole-body insulin sensitivity was assessed using the hyperinsulinemic-euglycemic clamp procedure in conjunction with glucose tracer infusion. Six subjects in the obese-NAFLD group were also evaluated before and after a diet-induced weight loss of 10%.RESULTS The contribution of hepatic DNL to IHTG-palmitate was 11%, 19%, and 38% in the lean, obese, and obese-NAFLD groups, respectively. Hepatic DNL was inversely correlated with hepatic and whole-body insulin sensitivity, but directly correlated with 24-hour plasma glucose and insulin concentrations. Weight loss decreased IHTG content, in conjunction with a decrease in hepatic DNL and 24-hour plasma glucose and insulin concentrations.CONCLUSIONS These data suggest hepatic DNL is an important regulator of IHTG content and that increases in circulating glucose and insulin stimulate hepatic DNL in individuals with NAFLD. Weight loss decreased IHTG content, at least in part, by decreasing hepatic DNL.TRIAL REGISTRATION ClinicalTrials.gov NCT02706262.FUNDING This study was supported by NIH grants DK56341 (Nutrition Obesity Research Center), DK20579 (Diabetes Research Center), DK52574 (Digestive Disease Research Center), and RR024992 (Clinical and Translational Science Award), and by grants from the Academy of Nutrition and Dietetics Foundation, the College of Natural Resources of UCB, and the Pershing Square Foundation.

Authors

Gordon I. Smith, Mahalakshmi Shankaran, Mihoko Yoshino, George G. Schweitzer, Maria Chondronikola, Joseph W. Beals, Adewole L. Okunade, Bruce W. Patterson, Edna Nyangau, Tyler Field, Claude B. Sirlin, Saswata Talukdar, Marc K. Hellerstein, Samuel Klein

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 Total
Citations: 41 82 63 73 72 19 350
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (350)

Title and authors Publication Year
BMI trajectories are associated with NAFLD and advanced fibrosis via aging-inflammation mediation
Peng H, Zhao Z, Gong J, He K
BMC Public Health 2025
Impact of protein intake from a caloric-restricted diet on liver lipid metabolism in overweight and obese rats of different sexes
Tian Y, Gong J, He Z, Peng S, Huan Y, Cao H
Scientific Reports 2025
Natural History of Metabolic Dysfunction-Associated Steatotic Liver Disease: From Metabolic Syndrome to Hepatocellular Carcinoma
Alpízar Salazar M, Olguín Reyes SE, Medina Estévez A, Saturno Lobos JA, De Aldecoa Castillo JM, Carrera Aguas JC, Alaniz Monreal S, Navarro Rodríguez JA, Alpízar Sánchez DM
Medicina 2025
Protection Strategies Against Palmitic Acid-Induced Lipotoxicity in Metabolic Syndrome and Related Diseases
Ceja-Galicia ZA, Cespedes-Acuña CL, El-Hafidi M
International Journal of Molecular Sciences 2025
Identification of Interactive Genetic Loci Linked to Insulin Resistance in Metabolic Syndrome—An Update
Elfaki I, Mir R, Elnageeb ME, Hamadi A, Alharbi ZM, Bedaiwi RI, Javid J, Alrasheed T, Alatawi D, Alrohaf BM, Abunab MK, Muqri TA
Medicina 2025
The Triad of Risk: Linking MASLD, Cardiovascular Disease and Type 2 Diabetes; From Pathophysiology to Treatment
Michalopoulou E, Thymis J, Lampsas S, Pavlidis G, Katogiannis K, Vlachomitros D, Katsanaki E, Kostelli G, Pililis S, Pliouta L, Kountouri A, Papanikolaou IS, Lambadiari V, Ikonomidis I
Journal of Clinical Medicine 2025
Drug Advances in NAFLD: Individual and Combination Treatment Strategies of Natural Products and Small-Synthetic-Molecule Drugs
Wan X, Ma J, Bai H, Hu X, Ma Y, Zhao M, Liu J, Duan Z
Biomolecules 2025
Human Genetics of Metabolic Dysfunction-Associated Steatotic Liver Disease: from Variants to Cause to Precision Treatment
Vincent L. Chen, Annapurna Kuppa, Antonino Oliveri, Yanhua Chen, Prabhu Ponnandy, Puja B. Patel, Nicholette D. Palmer, Elizabeth K. Speliotes
Journal of Clinical Investigation 2025
Association between TyG related parameters and metabolic dysfunction associated fatty liver disease among nondiabetic individuals
Zhang Q, Liu Z, Zhang J, Yang S, Liu L
Scientific Reports 2025
Metabolic dysfunction-associated fatty liver disease and risk of nephrolithiasis: a sizeable cross-sectional study
Zheng S, Hua T, Yin G, Zhang W, Wang X, Qi L, Jing X, Fan Q, Yu X, Li Y
Frontiers in Endocrinology 2025
Hu-lu-su-pian ameliorates hepatic steatosis by regulating CIDEA expression in AKT-driven MASLD mice
Ren R, Wang Q, Deng D, Guo A, Chen X, Meng Y, Fang Y, Zheng G, Xu Z, Li M, Hu J
Frontiers in Pharmacology 2025
Metabolic Dysfunction-Associated Steatotic Liver Disease: Pathogenetic Links to Cardiovascular Risk
Ionescu VA, Gheorghe G, Bacalbasa N, Diaconu CC
Biomolecules 2025
METTL3 promotes the progression of non-alcoholic fatty liver disease by mediating m6A methylation of FAS
Li Q, Xiang J
Scientific Reports 2025
Weight loss in MASLD restores the balance of liver fatty acid sources
Jennifer E Lambert, Maria A. Ramos-Roman, Maressa Valdez, Jeffrey D. Browning, Thomas Rogers, Elizabeth J. Parks
Journal of Clinical Investigation 2025
Clinical significance of small dense low‐density lipoprotein cholesterol measurement in type 2 diabetes
Hirano T
Journal of Diabetes Investigation 2025
Analyzing MASLD interventional clinical trial registration based on the ClinicalTrials.gov database
Du H, Huang J, Wang Y, Wang C, Wang Y, Hou L, Li Y, Li Y, Su Q
BMC Gastroenterology 2025
The association between estimated glucose disposal rate and metabolic dysfunction-associated steatotic liver disease and liver fibrosis in US adults
Liu W, Li X, Chen L, Luo X
BMC Endocrine Disorders 2025
Non-Alcoholic Fatty Liver Disease (NAFLD) Management in the Community
Park Y, Ko KS, Rhee BD
International Journal of Molecular Sciences 2025
Unraveling the Mystery of Insulin Resistance: From Principle Mechanistic Insights and Consequences to Therapeutic Interventions
Mir MM, Jeelani M, Alharthi MH, Rizvi SF, Sohail SK, Wani JI, Sabah ZU, BinAfif WF, Nandi P, Alshahrani AM, Alfaifi J, Jehangir A, Mir R
International Journal of Molecular Sciences 2025
BRCA1 regulates glucose and lipid metabolism in diabetes mellitus with metabolic dysfunction-associated steatotic liver disease via the PI3K/Akt signaling pathway
Ma C, Yang X, Zhang L, Zhang J, Zhang Y, Hu X
PLOS One 2025
KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025
Sohn W, Lee YS, Kim SS, Kim JH, Jin YJ, Kim GA, Sung PS, Yoo JJ, Chang Y, Lee EJ, Lee HW, Choi M, Yu SJ, Jung YK, Jang BK
Clinical and Molecular Hepatology 2025
Liver specific transgenic expression of CYP7B1 attenuates early western diet-induced MASLD progression
Kakiyama G, Bai-Kamara N, Rodriguez-Agudo D, Takei H, Minowa K, Fuchs M, Biddinger S, Windle JJ, Subler MA, Murai T, Suzuki M, Nittono H, Sanyal A, Pandak WM
Journal of Lipid Research 2025
MetALD: New Perspectives on an Old Overlooked Disease
Ayares G, Diaz LA, Idalsoaga F, Alkhouri N, Noureddin M, Bataller R, Loomba R, Arab JP, Arrese M
Liver International 2025
Association Between Triglyceride and Incident Diabetes Mellitus: A Secondary Retrospective Analysis Based on a Chinese Cohort Study
Peng H, Wang B, Yang W, Jia R, Luo Y, Chen W
Journal of Multidisciplinary Healthcare 2025
Therapeutic Potential of Myricitrin in a db/db Mouse Model of Type 2 Diabetes
Kim SR, Kim YJ, Kim H, Park S, Jung UJ
Molecules 2025
Comparison of the predictive value of TyG index and METS-IR for OSA combined with NAFLD: a retrospective observational study based on a physical examination population
Li M, Wan Y, Wei Z, Lin W
BMC Gastroenterology 2025
Investigating the Effects of Gossypetin on Liver Health in Diet-Induced Pre-Diabetic Male Sprague Dawley Rats
Naidoo K, Khathi A
Molecules 2025
Association Between Alpha-1-Acid Glycoprotein and Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Adult Women
Fu Y, Zhang S, Zeng X, Qin H
Metabolites 2025
Lipogenesis and MASLD: re-thinking the role of SREBPs.
Nakagawa H
Archives of toxicology 2025
Multi Targeted Activity of Cocculus hirsutus through Modulation of DPP-IV and PTP-1B Leading to Enhancement of Glucose Uptake and Attenuation of Lipid Accumulation.
Bhuvaneswari D, Riitvek B, Lakshmi BS
Applied biochemistry and biotechnology 2025
Unraveling the role of muscle mass and strength in predicting type 2 diabetes risk: a systematic review.
Putranata H, Hengky A, Hartoko B
Acta diabetologica 2025
Combined effect of fasting blood glucose and serum uric acid on nonalcoholic fatty liver disease
Hao Y, Li X, Zhang Y, Zheng J, Miao Y, Tan J, Zhang Q
Lipids in Health and Disease 2025
Clinical characteristics of lean and non-lean non-alcoholic fatty liver disease: a cross-sectional study.
Xu M, Gong R, Xie J, Xu S, Wang S
Nutrition & metabolism 2025
Unraveling the triglyceride-glucose index: a key predictor of liver fat content and the amplifying role of BMI: evidence from a large physical examination data.
Liu SJ, Duan JH, Chen YY, Gu SL, He YH, Xue MM, Yue JY
Frontiers in endocrinology 2025
The HbA1c/HDL-C ratio as a screening indicator of NAFLD in U.S. adults: a cross-sectional NHANES analysis (2017–2020)
Wu J, Yu W, Huang L, Hou S, Huang Y, Huang Z, Dai Z, Yin J, Nie Z
BMC Gastroenterology 2025
Endocrine regulation of metabolic crosstalk between liver and brown adipose tissue by natural active ingredients.
Chen QC, Cai WF, Ni Q, Lin SX, Jiang CP, Yi YK, Liu L, Liu Q, Shen CY
International journal of obesity (2005) 2025
Proanthocyanidin and mitoglitazone suppress lipogenesis by targeting ferroptosis in metabolic dysfunction-associated steatohepatitis.
El-Naby SMA, Khedr NF, El-Ashmawy NE, Ibrahim AO
Naunyn-Schmiedeberg's archives of pharmacology 2025
Skeletal muscle and MASLD: Mechanistic and clinical insights
Marjot T, Armstrong MJ, Stine JG
Hepatology Communications 2025
Intestinal bacteria-derived extracellular vesicles in metabolic dysfunction-associated steatotic liver disease: From mechanisms to therapeutics
Qin LN, Yu YF, Ma L, Yu R
Molecules and Cells 2025
S-adenosylmethionine deficit disrupts very low-density lipoprotein metabolism promoting liver lipid accumulation in mice
Luque-Urbano MR, Fernández-Ramos D, Lopitz-Otsoa F, Gutiérrez de Juan V, Bizkarguenaga M, Castro-Espadas L, Hermoso-Martínez U, Barbier-Torres L, Lu SC, Millet O, Mato JM
Journal of Lipid Research 2025
Hepatic stellate cell-specific Kcnma1 deletion mitigates metabolic dysfunction-associated steatotic liver disease progression via upregulating Amphiregulin secretion
Zou Y, Wu J, Cheng S, Cheng D, Chen T, Guo X, Tang L, Su X, Zhang M, Zhang X, Liu Y, Zhang J, Bao Q, Hou S, Sun P, Li Y, Han B
Molecular Metabolism 2025
Adipocyte lipin 1 is positively associated with metabolic health in humans and regulates systemic metabolism in mice.
Andrew LaPoint, Jason M Singer, Daniel Ferguson, Trevor M Shew, Katie RenKemeyer, Hector H Palacios, Rachael L Field, Mahalakshmi Shankaran, Gordon I. Smith, Jun Yoshino, Mai He, Gary J Patti, Marc Hellerstein, Samuel Klein, Jonathan R. Brestoff, Brian N Finck, Andrew Lutkewitte
Journal of Clinical Investigation 2024
Development and Validation of a Risk Prediction Model for NAFLD: A Study Based on a Physical Examination Population
Yang C, Du T, Zhao Y, Qian Y, Tang J, Li X, Ma L
2024
Gut microbiota and metabolite interface-mediated hepatic inflammation
Yang M, Massad K, Kimchi ET, Staveley-O\u2019Carroll KF, Li G
2024
Hexokinase-linked glycolytic overload and unscheduled glycolysis in hyperglycemia-induced pathogenesis of insulin resistance, beta-cell glucotoxicity, and diabetic vascular complications.
Rabbani N, Thornalley PJ
Frontiers in Endocrinology 2024
Association between nonalcoholic fatty liver disease and increased glucose-to-albumin ratio in adults without diabetes
Wang S, Lin X, Zhu C, Dong Y, Guo Y, Xie Z, He X, Ju W, Chen M
Frontiers in Endocrinology 2024
Proanthocyanidins-Based Synbiotics as a Novel Strategy for Nonalcoholic Fatty Liver Disease (NAFLD) Risk Reduction
Thilakarathna WP, Rupasinghe HP
Molecules (Basel, Switzerland) 2024
Surveillance of the liver in type 2 diabetes: important but unfeasible?
Qadri S, Yki-Järvinen H
Diabetologia 2024
Association of Hepatic Steatosis and Fibrosis Indices With Insulin Sensitivity and Inflammation in the POP-ABC Study.
Colon-Barreto B, Asuzu P, Ebenibo S, Dagogo-Jack S
Journal of the Endocrine Society 2024
The metabolic profiles and body composition of non-obese metabolic associated fatty liver disease.
Zhang Y, Xiang L, Qi F, Cao Y, Zhang W, Lv T, Zhou X
Frontiers in Endocrinology 2024
Metabolic flux analysis in adipose tissue reprogramming
Medina A, Bruno J, Alemán JO
2024
Association between TyG index trajectory and new-onset lean NAFLD: a longitudinal study
Liu H, Chen J, Qin Q, Yan S, Wang Y, Li J, Ding S
Frontiers in Endocrinology 2024
Hepatic insulin resistance and muscle insulin resistance are characterized by distinct postprandial plasma metabolite profiles: a cross-sectional study.
Gijbels A, Erdős B, Trouwborst I, Jardon KM, Adriaens ME, Goossens GH, Blaak EE, Feskens EJM, Afman LA
Cardiovascular Diabetology 2024
Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches.
Mahmoudi SK, Tarzemani S, Aghajanzadeh T, Kasravi M, Hatami B, Zali MR, Baghaei K
European Journal of Medical Research 2024
Are all sugars equal? Role of the food source in physiological responses to sugars with an emphasis on fruit and fruit juice.
Gonzalez JT
European Journal of Nutrition 2024
Dimethyloxalylglycine Suppresses SREBP1c and Lipogenic Gene Expressions in Hepatocytes Independently of HIF1A.
Kwon YS, Cho YE, Kim Y, Koh M, Hwang S
Current issues in molecular biology 2024
Effects of NPY-2 Receptor Antagonists, Semaglutide, PYY(3-36), and Empagliflozin on Early MASLD in Diet-Induced Obese Rats.
Kloock S, Haerting N, Herzog G, Oertel M, Geiger N, Geier A, Sequeira V, Nickel A, Kohlhaas M, Fassnacht M, Dischinger U
Nutrients 2024
Glucagon-like Peptide-1 Receptor Agonists-A Potential New Medication for Pediatric Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD).
Choi E, Ramirez Tovar A, He Z, Soler Rodriguez DM, Vos MB, Arora S, Fadoju D
2024
A Review: Cytochrome P450 in Alcoholic and Non-Alcoholic Fatty Liver Disease
Jiang YJ, Cao YM, Cao YB, Yan TH, Jia CL, He P
2024
Bacteroides and NAFLD: pathophysiology and therapy
Zhang J, Zhou J, He Z, Li H
Frontiers in microbiology 2024
Potassium affects the association between dietary intake of vitamin C and NAFLD among adults in the United States
Liu XH, Chen HK, Luo J, He XP, Zhang WL, Chen Y, Li XJ, Lan QW, Ma XM, Guo XG
PloS one 2024
Cardiometabolic characteristics of people with metabolically healthy and unhealthy obesity
Petersen MC, Smith GI, Palacios HH, Farabi SS, Yoshino M, Yoshino J, Cho K, Davila-Roman VG, Shankaran M, Barve RA, Yu J, Stern JH, Patterson BW, Hellerstein MK, Shulman GI, Patti GJ, Klein S
Cell Metabolism 2024
Oligonucleotide therapies for nonalcoholic steatohepatitis
Li S, Xiong F, Zhang S, Liu J, Gao G, Xie J, Wang Y
2024
Association between processed and unprocessed red meat consumption and risk of nonalcoholic fatty liver disease: A systematic review and dose-response meta-analysis
Zhou Q, Hu H, Hu L, Liu S, Chen J, Tong S
Journal of Global Health 2024
Animal studies of sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease.
Makri ES, Makri E, Goulas A, Xanthopoulos K, Polyzos SA
Annals of Gastroenterology 2024
Associations between estimated glucose disposal rate and arterial stiffness and mortality among US adults with non-alcoholic fatty liver disease.
Song J, Ma R, Yin L
Frontiers in Endocrinology 2024
A long-acting LEAP2 analog reduces hepatic steatosis and inflammation and causes marked weight loss in mice
Shankar K, Metzger NP, Lawrence C, Gupta D, Osborne-Lawrence S, Varshney S, Singh O, Richard CP, Zaykov AN, Rolfts R, DuBois BN, Perez-Tilve D, Mani BK, Hammer ST, Zigman JM
Molecular Metabolism 2024
Exploring the impact of lipid droplets on the evolution and progress of hepatocarcinoma.
Maurotti S, Geirola N, Frosina M, Mirarchi A, Scionti F, Mare R, Montalcini T, Pujia A, Tirinato L
Frontiers in Cell and Developmental Biology 2024
Envisioning how to advance the MASH field.
Allen AM, Younossi ZM, Diehl AM, Charlton MR, Lazarus JV
Nature reviews. Gastroenterology & hepatology 2024
Metabolic Responses to an Acute Glucose Challenge: The Differential Effects of Eight Weeks of Almond vs. Cracker Consumption in Young Adults
Dhillon J, Pandey S, Newman JW, Fiehn O, Ortiz RM
2024
The signaling pathways in obesity‐related complications
Chandrasekaran P, Weiskirchen R
Journal of Cell Communication and Signaling 2024
New advances in drug development for metabolic dysfunction-associated diseases and alcohol-associated liver disease
Zhang J, Li Y, Yang L, Ma N, Qian S, Chen Y, Duan Y, Xiang X, He Y
Cell & Bioscience 2024
Metabolic complications of psychotropic medications in psychiatric disorders: Emerging role of de novo lipogenesis and therapeutic consideration
Khan MM, Khan ZA, Khan MA
World Journal of Psychiatry 2024
The correlation between hepatic controlled attenuation parameter (CAP) value and insulin resistance (IR) was stronger than that between body mass index, visceral fat area and IR
Li Z, Liu R, Gao X, Hou D, Leng M, Zhang Y, Du M, Zhang S, Li C
Diabetology & metabolic syndrome 2024
Association between hemoglobin and non-alcoholic fatty liver disease (NAFLD) in United States adults: Results from NHANES 2017–2020
Yao K, Chen Z, Zhou W, Liu Z, Cui W
Preventive Medicine Reports 2024
Triglyceride glucose index as a predictor for non-alcoholic fatty liver disease: insights from a longitudinal analysis in non-obese individuals
Ning Q, Zheng K, Yan J, Zhu C
Frontiers in Medicine 2024
Zinc finger BED-type containing 3 promotes hepatic steatosis by interacting with polypyrimidine tract-binding protein 1.
Wu Y, Yang M, Wu SB, Luo PQ, Zhang C, Ruan CS, Cui W, Zhao QR, Chen LX, Meng JJ, Song Q, Zhang WJ, Pei QQ, Li F, Zeng T, Du HX, Xu LX, Zhang W, Zhang XX, Luo XH
Diabetologia 2024
Are dietary factors associated with cardiometabolic risk factors in patients with non-alcoholic fatty liver disease?
Topal GG, Sevim S, Gumus D, Balaban HY, Karçaaltıncaba M, Kizil M
PeerJ 2024
Diabetes Mellitus – Progress and Opportunities in the Evolving Epidemic
Abel ED, Gloyn AL, Evans-Molina C, Joseph JJ, Misra S, Pajvani UB, Simcox J, Susztak K, Drucker DJ
Cell 2024
Hepatic glucokinase regulatory protein and carbohydrate response element binding protein attenuation reduce de novo lipogenesis but do not mitigate intrahepatic triglyceride accumulation in Aldob deficiency
Buziau AM, Oosterveer MH, Wouters K, Bos T, Tolan DR, Agius L, Ford BE, Cassiman D, Stehouwer CD, Schalkwijk CG, Brouwers MC
Molecular Metabolism 2024
Elevations in plasma glucagon are associated with reduced insulin clearance after ingestion of a mixed-macronutrient meal in people with and without type 2 diabetes.
Smith K, Taylor GS, Peeters W, Walker M, Perazzolo S, Atabaki-Pasdar N, Bowden Davies KA, Karpe F, Hodson L, Stevenson EJ, West DJ
Diabetologia 2024
Pathophysiological Relationship between Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Therapeutic Approaches
Ferdous SE, Ferrell JM
International Journal of Molecular Sciences 2024
Diabetes and Osteoarthritis: Exploring the Interactions and Therapeutic Implications of Insulin, Metformin, and GLP-1-Based Interventions
Halabitska I, Babinets L, Oksenych V, Kamyshnyi O
Biomedicines 2024
Innovative treatments for obesity and NAFLD: A bibliometric study on antioxidants, herbs, phytochemicals, and natural compounds
Pezzino S, Sofia M, Mazzone C, Litrico G, Greco LP, Gallo L, La Greca G, Latteri S
Heliyon 2024
The role of adipose tissue dysfunction in hepatic insulin resistance and T2D
Sancar G, Birkenfeld AL
The Journal of Endocrinology 2024
Nonlinear relationship between the triglyceride–glucose index and alanine aminotransferase in children with short stature
Zhao Q, Li Y, Zhang M, Ban B
Scientific Reports 2024
Association between TyG index and risk of carotid atherosclerosis in NAFLD patients: a retrospective cohort study
Huang W, Wang H, Shen Z, Wang X, Yu X
Frontiers in Endocrinology 2024
Global (13)C tracing and metabolic flux analysis of intact human liver tissue ex vivo.
Grankvist N, Jönsson C, Hedin K, Sundqvist N, Sandström P, Björnsson B, Begzati A, Mickols E, Artursson P, Jain M, Cedersund G, Nilsson R
Nature metabolism 2024
Correlation between ratio of fasting blood glucose to high density lipoprotein cholesterol in serum and non-alcoholic fatty liver disease in American adults: a population based analysis
Jin X, Xu J, Weng X
Frontiers in Medicine 2024
Association of circulating visfatin level and metabolic fatty liver disease: An updated meta-analysis and systematic review
Chen S, Wu K, Ke Y, Chen S, He R, Zhang Q, Shen C, Li Q, Ruan Y, Zhu Y, Du K, Hu J, Liu S
Medicine 2024
Mechanisms of Non-alcoholic Fatty Liver Disease and Beneficial Effects of Semaglutide: A Review
Alfawaz S, Burzangi A, Esmat A
Cureus 2024
The nonlinear connection between relative fat mass and non-alcoholic fatty liver disease in the Japanese population: an analysis based on data from a cross-sectional study
Cao C, Huang M, Han Y, Zhang X, Hu H, Wang Y
Diabetology & Metabolic Syndrome 2024
Diagnostic Utility of Triglyceride-Glucose Index in Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study on Lean Population
Han T, Li Y, Xiao J, Gong H, Deng F, Jiang W, Wang C, Chen F, Zhang C, Deng J, Zhang Y
Diabetes, Metabolic Syndrome and Obesity 2024
Impact of Remnant Cholesterol on Cardiovascular Risk in Diabetes.
Elías-López D, Wadström BN, Vedel-Krogh S, Kobylecki CJ, Nordestgaard BG
Current diabetes reports 2024
Mixed active metabolites of the SNP-6 series of novel compounds mitigate metabolic dysfunction-associated steatohepatitis and fibrosis: promising results from pre-clinical and clinical trials.
Ho HT, Shih YL, Huang TY, Fang WH, Liu CH, Lin JC, Hsiang CW, Chu KM, Hsiong CH, Chen GJ, Wu YE, Hao JY, Liang CW, Hu OY
Journal of translational medicine 2024
Drivers of cardiovascular disease in metabolic dysfunction-associated steatotic liver disease: the threats of oxidative stress.
Minetti ET, Hamburg NM, Matsui R
Frontiers in cardiovascular medicine 2024
Dissociation between liver fat content and fasting metabolic markers of selective hepatic insulin resistance in humans
Westcott FA, Nagarajan SR, Parry SA, Savic D, Green CJ, Marjot T, Johnson E, Cornfield T, Mózes FE, O\u2019Rourke P, Mendall J, Dearlove D, Fielding B, Smith K, Tomlinson JW, Hodson L
European Journal of Endocrinology 2024
Chinese herbal formula in the treatment of metabolic dysfunction-associated steatotic liver disease: current evidence and practice
Tao SH, Lei YQ, Tan YM, Yang YB, Xie WN
Frontiers in Medicine 2024
Amelioration of fructose-induced hepatic lipid accumulation by vitamin D(3) supplementation and high-intensity interval training in male Sprague‒Dawley rats.
Shokri B, Mohebbi H, Mehrabani J
Lipids in health and disease 2024
BCAA was more closely associated with visceral fat area than subcutaneous fat area in patients of type 2 diabetes mellitus: a cross-sectional study.
Cai X, Li W, Wang L, Shi Y, Gao J, Wang H, Lei T, Lu J
BMC endocrine disorders 2024
Transcriptional Regulation of De Novo Lipogenesis by SIX1 in Liver Cancer Cells.
Li L, Zhang X, Xu G, Xue R, Li S, Wu S, Yang Y, Lin Y, Lin J, Liu G, Gao S, Zhang Y, Ye Q
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024
High-fat-diet-induced hepatic insulin resistance per se attenuates murine de novo lipogenesis
Goedeke L, Strober JW, Suh R, Paolella LM, Li X, Rogers JC, Petersen MC, Nasiri AR, Casals G, Kahn M, Cline GW, Samuel VT, Shulman GI, Vatner DF
iScience 2024
Qinlian Hongqu Decoction Modulates FXR/TGR5/GLP-1 Pathway to Improve Insulin Resistance in NAFLD Mice: Bioinformatics and Experimental Study
Zhang Z, He Y, Zhao M, He X, Zhou Z, Yue Y, Shen T, Liu J, Zhang G, Zhang Y
ACS Omega 2024
Single Dose of Phosphatidylinositol 3-Kinase Inhibitor Alpelisib Induces Insulin Resistance in Healthy Adults: A Randomized Feasibility Study.
Cook JR, Bedeir N, Sone ZD, Wattacheril J, Ginsberg HN, Laferrère B
Diabetes 2024
Association Between Fatty Liver Index and Incidence of Cataract Surgery in Individuals Aged 50 Years and Older Based on the Korean National Health Insurance Service-Health Screening Cohort (NHIS-HEALS) Data: Longitudinal Retrospective Cohort Study.
Kim Y, Kim J, Seo EJ, Kim KT, Lee JW, Kim J, Kang HT
JMIR public health and surveillance 2024
Dodecanedioic acid prevents and reverses metabolic‐associated liver disease and obesity and ameliorates liver fibrosis in a rodent model of diet‐induced obesity
Angelini G, Russo S, Carli F, Infelise P, Panunzi S, Bertuzzi A, Caristo ME, Lembo E, Calce R, Bornstein SR, Gastaldelli A, Mingrone G
The FASEB Journal 2024
Myokines and Their Potential Protective Role Against Oxidative Stress in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Bucarey JL, Trujillo-González I, Paules EM, Espinosa A
Antioxidants 2024
Lipid metabolism in MASLD and MASH: From mechanism to the clinic
Carli F, Della Pepa G, Sabatini S, Vidal Puig A, Gastaldelli A
JHEP Reports 2024
Targeting acetyl-CoA carboxylases for the treatment of MASLD
Mateo-Marín MA, Alves-Bezerra M
Journal of Lipid Research 2024
Glycerol Kinase Drives Hepatic de novo Lipogenesis and Triglyceride Synthesis in Nonalcoholic Fatty Liver by Activating SREBP‐1c Transcription, Upregulating DGAT1/2 Expression, and Promoting Glycerol Metabolism
Ouyang S, Zhuo S, Yang M, Zhu T, Yu S, Li Y, Ying H, Le Y
Advanced Science 2024
A Comprehensive Analysis of Liver Lipidomics Signature in Adults with Metabolic Dysfunction-Associated Steatohepatitis—A Pilot Study
Mouskeftara T, Kalopitas G, Liapikos T, Arvanitakis K, Theocharidou E, Germanidis G, Gika H
International Journal of Molecular Sciences 2024
Plasma C24:0 ceramide impairs adipose tissue remodeling and promotes liver steatosis and glucose imbalance in offspring of rats
Camacho-Morales A, Noriega LG, Sánchez-García A, Torre-Villalvazo I, Vázquez-Manjarrez N, Maldonado-Ruiz R, Cárdenas-Tueme M, Villegas-Romero M, Alamilla-Martínez I, Rodriguez-Rocha H, Garcia-Garcia A, Corona JC, Tovar AR, Saville J, Fuller M, Gonzalez-Gonzalez JG, Rivas-Estilla AM
Heliyon 2024
Pathophysiology and Treatment of Prediabetes and Type 2 Diabetes in Youth
Bacha F, Hannon TS, Tosur M, Pike JM, Butler A, Tommerdahl KL, Zeitler PS
Diabetes Care 2024
Knockdown of RASD1 improves MASLD progression by inhibiting the PI3K/AKT/mTOR pathway
Zeng G, Liu X, Zheng Z, Zhao J, Zhuo W, Bai Z, Lin E, Cai S, Cai C, Li P, Zou B, Li J
Lipids in Health and Disease 2024
The Role of SHBG as a Marker in Male Patients with Metabolic-Associated Fatty Liver Disease: Insights into Metabolic and Hormonal Status
Fodor Duric L, Belčić V, Oberiter Korbar A, Ćurković S, Vujicic B, Gulin T, Muslim J, Gulin M, Grgurević M, Catic Cuti E
Journal of Clinical Medicine 2024
Triglycerides to apolipoprotein A1 ratio: an effective insulin resistance-associated index in identifying metabolic dysfunction-associated fatty liver disease in type 2 diabetes mellitus
Wang W, Chen Y, Tu M, Chen HJ
Frontiers in Endocrinology 2024
New Insights into AMPK, as a Potential Therapeutic Target in Metabolic Dysfunction-Associated Steatotic Liver Disease and Hepatic Fibrosis
An H, Jang Y, Choi J, Hur J, Kim S, Kwon Y
Biomolecules & Therapeutics 2024
Potential therapeutic strategies for MASH: from preclinical to clinical development
Xie Z, Li Y, Cheng L, Huang Y, Rao W, Shi H, Li J
Life Metabolism 2024
Physiological and pathophysiological actions of insulin in the liver
Kubota N, Kubota T, Kadowaki T
Endocrine Journal 2024
Adipose Tissue Biology and Effect of Weight Loss in Women With Lipedema
Cifarelli V, Smith GI, Gonzalez-Nieves S, Samovski D, Palacios HH, Yoshino J, Stein RI, Fuchs A, Wright TF, Klein S
Diabetes 2024
A hierarchical hepatic de novo lipogenesis substrate supply network utilizing pyruvate, acetate, and ketones
Rauckhorst AJ, Sheldon RD, Pape DJ, Ahmed A, Falls-Hubert KC, Merrill RA, Brown RF, Deshmukh K, Vallim TA, Deja S, Burgess SC, Taylor EB
Cell metabolism 2024
Histological improvements following energy restriction and exercise: The role of insulin resistance in resolution of MASH
Mucinski JM, Salvador AF, Moore MP, Fordham TM, Anderson JM, Shryack G, Cunningham R, Lastra G, Gaballah AH, Diaz-Arias A, Ibdah JA, Rector RS, Parks EJ
Journal of hepatology 2024
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH).
Do A, Zahrawi F, Mehal WZ
Nature reviews. Drug discovery 2024
Insights into the roles and pathomechanisms of ceramide and sphigosine-1-phosphate in nonalcoholic fatty liver disease
Zhu C, Huai Q, Zhang X, Dai H, Li X, Wang H
International journal of biological sciences 2023
Persistent fasting lipogenesis links impaired ketogenesis to elevated citrate synthase flux in humans with non-alcoholic fatty liver
Xiaorong Fu, Justin Fletcher, Stanisław Deja, Melissa Inigo, Shawn Burgess, Jeffrey Browning
Journal of Clinical Investigation 2023
Waist Circumference Is an Essential Factor in Predicting Insulin Resistance and Early Detection of Metabolic Syndrome in Adults
Ramírez-Manent JI, Jover AM, Martinez CS, Tomás-Gil P, Martí-Lliteras P, López-González ÁA
Nutrients 2023
The spleen-strengthening and liver-draining herbal formula treatment of non-alcoholic fatty liver disease by regulation of intestinal flora in clinical trial
Hui D, Liu L, Azami NL, Song J, Huang Y, Xu W, Wu C, Xie D, Jiang Y, Bian Y, Sun M
Frontiers in Endocrinology 2023
Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives
Clayton-Chubb D, Kemp W, Majeed A, Lubel JS, Hodge A, Roberts SK
Nutrients 2023
An Egg White-Derived Peptide Enhances Systemic Insulin Sensitivity and Modulates Markers of Non-Alcoholic Fatty Liver Disease in Obese, Insulin Resistant Mice
de Campos Zani SC, Wang R, Veida-Silva H, Clugston RD, Yue JT, Mori MA, Wu J, Chan CB
Metabolites 2023
A bibliometric analysis and visualization of nonalcoholic fatty liver disease from 2012 to 2021.
Li Z, Cao S, Zhao S, Kang N
Clinical and Experimental Medicine 2023
De novo lipogenesis fuels adipocyte autophagosome and lysosome membrane dynamics
Rowland LA, Guilherme A, Henriques F, DiMarzio C, Munroe S, Wetoska N, Kelly M, Reddig K, Hendricks G, Pan M, Han X, Ilkayeva OR, Newgard CB, Czech MP
Nature Communications 2023
Hormonal regulation of metabolism—recent lessons learned from insulin and estrogen
Tao Z, Cheng Z
Clinical science (London, England : 1979) 2023
Mouse strain-dependent variation in metabolic associated fatty liver disease (MAFLD): a comprehensive resource tool for pre-clinical studies
Karimkhanloo H, Keenan SN, Bayliss J, De Nardo W, Miotto PM, Devereux CJ, Nie S, Williamson NA, Ryan A, Watt MJ, Montgomery MK
Scientific Reports 2023
Heterogeneity in the effect of weight loss on insulin sensitivity and markers of metabolic health
Bettina Mittendorfer, Brandon Kayser, Mihoko Yoshino, Jun Yoshino, Jeramie Watrous, Mohit Jain, Bruce Patterson, Samuel Klein
JCI Insight 2023
From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications
Boccatonda A, Andreetto L, D\u2019Ardes D, Cocco G, Rossi I, Vicari S, Schiavone C, Cipollone F, Guagnano MT
Biomedicines 2023
Small Intestinal Bacterial Overgrowth and Non-Alcoholic Fatty Liver Disease: What Do We Know in 2023?
Gudan A, Kozłowska-Petriczko K, Wunsch E, Bodnarczuk T, Stachowska E
Nutrients 2023
Fructose drives de novo lipogenesis affecting metabolic health
Geidl-Flueck B, Gerber PA
The Journal of endocrinology 2023
MPEP Attenuates Intrahepatic Fat Accumulation in Obese Mice
Ferrigno A, Cagna M, Bosco O, Trucchi M, Berardo C, Nicoletti F, Vairetti M, Di Pasqua LG
International journal of molecular sciences 2023
Temporal Relationship Between Insulin Resistance and Lipid Accumulation After Bariatric Surgery: a Multicenter Cohort Study.
Tang H, Ling J, Meng H, Wu L, Zhu L, Zhu S
Obesity surgery 2023
Unravelling the role of obesity and lipids during tumor progression
Zhao J, Lee K, Toh HC, Lam KP, Neo SY
Frontiers in pharmacology 2023
Therapeutic Potentials of Reducing Liver Fat in Non-Alcoholic Fatty Liver Disease: Close Association with Type 2 Diabetes
Tsamos G, Vasdeki D, Koufakis T, Michou V, Makedou K, Tzimagiorgis G
Metabolites 2023
Physiological and pathological roles of lipogenesis.
Jeon YG, Kim YY, Lee G, Kim JB
Nature metabolism 2023
The role of hepatokines in NAFLD.
Stefan N, Schick F, Birkenfeld AL, Häring HU, White MF
Cell Metabolism 2023
Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL)
Mocciaro G, Allison M, Jenkins B, Azzu V, Huang-Doran I, Herrera-Marcos LV, Hall Z, Murgia A, Susan D, Frontini M, Vidal-Puig A, Koulman A, Griffin JL, Vacca M
Molecular Metabolism 2023
Metabolic Disturbance of High-Saturated Fatty Acid Diet in Cognitive Preservation.
Rivas-Domínguez A, Mohamed-Mohamed H, Jimenez-Palomares M, García-Morales V, Martinez-Lopez L, Orta ML, Ramos-Rodriguez JJ, Bermudez-Pulgarin B
International journal of molecular sciences 2023
Lipid droplet biogenesis and functions in health and disease.
Zadoorian A, Du X, Yang H
Nature reviews. Endocrinology 2023
Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease
Bhat N, Mani A
Nutrients 2023
Diet and Exercise Exert a Differential Effect on Glucose Metabolism Markers According to the Degree of NAFLD Severity.
Bianco A, Franco I, Curci R, Bonfiglio C, Campanella A, Mirizzi A, Fucilli F, Di Giovanni G, Giampaolo N, Pesole PL, Osella AR
Nutrients 2023
Sex, Nutrition, and NAFLD: Relevance of Environmental Pollution.
Dolce A, Della Torre S
Nutrients 2023
Type 2 Diabetes Mellitus, Non-Alcoholic Fatty Liver Disease, and Metabolic Repercussions: The Vicious Cycle and Its Interplay with Inflammation
Frankowski R, Kobierecki M, Wittczak A, Różycka-Kosmalska M, Pietras T, Sipowicz K, Kosmalski M
International journal of molecular sciences 2023
Lean nonalcoholic fatty liver disease and sarcopenia.
Chen M, Cao Y, Ji G, Zhang L
Frontiers in Endocrinology 2023
Liver Fat - Gone, but Not Forgotten?
Titchenell PM, Baur JA
Cellular and Molecular Gastroenterology and Hepatology 2023
Editorial: Diabetes and non-alcoholic fatty liver disease: points of physiological and mechanistic intersection and current co-therapeutic approaches.
Giannoukakis N, McCommis KS
Frontiers in Endocrinology 2023
Predictive value of the Framingham steatosis index for cardiovascular risk: a nationwide population-based cohort study.
Cho YK, Kim M, Kim YJ, Jung CH, Lee WJ, Park JY
Frontiers in Cardiovascular Medicine 2023
Aetiology of Type 2 diabetes in people with a 'normal' body mass index: testing the personal fat threshold hypothesis.
Taylor R, Barnes AC, Hollingsworth KG, Irvine KM, Solovyova AS, Clark L, Kelly T, Martin-Ruiz C, Romeres D, Koulman A, Meek CM, Jenkins B, Cobelli C, Holman RR
Clinical science (London, England : 1979) 2023
Nucleoside diphosphate kinases 1 and 2 regulate a protective liver response to a high-fat diet
Iuso D, Garcia-Saez I, Couté Y, Yamaryo-Botté Y, Boeri Erba E, Adrait A, Zeaiter N, Tokarska-Schlattner M, Jilkova ZM, Boussouar F, Barral S, Signor L, Couturier K, Hajmirza A, Chuffart F, Bourova-Flin E, Vitte AL, Bargier L, Puthier D, Decaens T, Rousseaux S, Botté C, Schlattner U, Petosa C, Khochbin S
Science Advances 2023
Upregulation of WDR6 drives hepatic de novo lipogenesis in insulin resistance in mice.
Yao Z, Gong Y, Chen W, Shao S, Song Y, Guo H, Li Q, Liu S, Wang X, Zhang Z, Wang Q, Xu Y, Wu Y, Wan Q, Zhao X, Xuan Q, Wang D, Lin X, Xu J, Liu J, Proud CG, Wang X, Yang R, Fu L, Niu S, Kong J, Gao L, Bo T, Zhao J
Nature metabolism 2023
Micropatterned primary hepatocyte co-culture (HEPATOPAC) for fatty liver disease modeling and drug screening
Cottier KE, Bhalerao D, Lewis C, Gaffney J, Heyward SA
Scientific Reports 2023
Combination of an ACLY inhibitor with a GLP-1R agonist exerts additive benefits on nonalcoholic steatohepatitis and hepatic fibrosis in mice
Desjardins EM, Wu J, Lavoie DC, Ahmadi E, Townsend LK, Morrow MR, Wang D, Tsakiridis EE, Batchuluun B, Fayyazi R, Kwiecien JM, Tsakiridis T, Lally JS, Paré G, Pinkosky SL, Steinberg GR
Cell reports. Medicine 2023
Measurement of gluconeogenesis by 2H2O labeling and mass isotopomer distribution analysis
Ziari N, Hellerstein M
The Journal of biological chemistry 2023
The role of autophagy in the treatment of type II diabetes and its complications: a review
Zhao X, Bie LY, Pang DR, Li X, Yang LF, Chen DD, Wang YR, Gao Y
Frontiers in Endocrinology 2023
Effects of hepatic mitochondrial pyruvate carrier deficiency on de novo lipogenesis and glycerol-mediated gluconeogenesis in mice
Yiew NK, Deja S, Ferguson D, Cho K, Jarasvaraparn C, Jacome-Sosa M, Lutkewitte AJ, Mukherjee S, Fu X, Singer JM, Patti GJ, Burgess SC, Finck BN
2023
The Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Body Composition in Type 2 Diabetes Mellitus: A Narrative Review
Jahangiri S, Malek M, Kalra S, Khamseh ME
Diabetes Therapy 2023
Liver acts as a metabolic gate for the traumatic brain injury pathology: Protective action of thyroid hormone
Khandelwal M, Krishna G, Ying Z, Gomez-Pinilla F
2023
MiR-143-3p/FNDC5 axis: a novel regulator of insulin sensitivity.
Li B, Dong Y, Hu S, Liu T
Endocrine 2023
The Impact and Burden of Dietary Sugars on the Liver
Huneault HE, Ramirez Tovar A, Sanchez-Torres C, Welsh JA, Vos MB
Hepatology Communications 2023
Effects of hepatic mitochondrial pyruvate carrier deficiency on de novo lipogenesis and gluconeogenesis in mice
Yiew NK, Deja S, Ferguson D, Cho K, Jarasvaraparn C, Jacome-Sosa M, Lutkewitte AJ, Mukherjee S, Fu X, Singer JM, Patti GJ, Burgess SC, Finck BN
iScience 2023
The Role of Epigenetic Control of Mitochondrial (Dys)Function in MASLD Onset and Progression
Caputo V, Tarantino G, Santini SJ, Fracassi G, Balsano C
Nutrients 2023
Molecular Aspects of MAFLD—New Insights on Pathogenesis and Treatment
Filipovic B, Marjanovic-Haljilji M, Mijac D, Lukic S, Kapor S, Kapor S, Starcevic A, Popovic D, Djokovic A
Current issues in molecular biology 2023
Replacement of dietary carbohydrate with protein increases fat mass and reduces hepatic triglyceride synthesis and content in female obese Zucker rats.
Dawson MA, Hennigar SR, Shankaran M, Kelley AM, Anderson BJ, Nyangau E, Field TJ, Evans WJ, Hellerstein MK, McClung JP, Pasiakos SM, Berryman CE
Physiological Reports 2023
A medium-chain fatty acid analogue prevents hepatosteatosis and decreases inflammatory lipid metabolites in a murine model of parenteral nutrition-induced hepatosteatosis.
Cho BS, Fligor SC, Fell GL, Secor JD, Tsikis ST, Pan A, Yu LJ, Ko VH, Dao DT, Anez-Bustillos L, Hirsch TI, Lund J, Rustan AC, Fraser DA, Gura KM, Puder M
PloS one 2023
Effects Of Exercise Training And Chlorogenic Acid Supplementation On Hepatic Lipid Metabolism In Prediabetes Mice.
Shirkhani S, Marandi SM, Nasr-Esfahani MH, Kim SK
Diabetes & Metabolism Journal 2023
Unmasking the enigma of lipid metabolism in metabolic dysfunction-associated steatotic liver disease: from mechanism to the clinic
Rao G, Peng X, Li X, An K, He H, Fu X, Li S, An Z
Frontiers in Medicine 2023
Dietary Regulation of Hepatic Triacylglycerol Content—the Role of Eucaloric Carbohydrate Restriction with Fat or Protein Replacement
Lundsgaard AM, Bojsen-Møller KN, Kiens B
Advances in Nutrition 2023
The vascular endothelial growth factor system—a new player in the pathogenesis and development of metabolic dysfunction-associated steatotic liver disease
Grønbæk H, Mellemkjær A, Nielsen S, Magkos F
Hepatobiliary surgery and nutrition 2023
Nonalcoholic Fatty Liver Disease Incidence and Remission and Their Predictors During 7 Years of Follow-up Among Finns.
Korpimäki S, Rovio SP, Juonala M, Hutri-Kähönen N, Lehtimäki T, Laitinen TP, Tossavainen P, Jokinen E, Loo BM, Männistö S, Tammelin T, Haarala A, Aatola H, Komar G, Viikari J, Raitakari O, Kähönen M, Pahkala K
The Journal of clinical endocrinology and metabolism 2023
Insulin Regulation of Hepatic Lipid Homeostasis
Uehara K, Santoleri D, Whitlock AE, Titchenell PM
Comprehensive Physiology 2023
The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review.
Zachou M, Flevari P, Nasiri-Ansari N, Varytimiadis C, Kalaitzakis E, Kassi E, Androutsakos T
European Journal of Clinical Pharmacology 2023
What Does Sarcopenia Have to Do with Nonalcoholic Fatty Liver Disease?
Ferenc K, Jarmakiewicz-Czaja S, Filip R
Life Sciences 2023
MiR-192-5p Ameliorates Hepatic Lipid Metabolism in Non-Alcoholic Fatty Liver Disease by Targeting Yy1.
Ma L, Song H, Zhang CY, Hou D
Biomolecules 2023
Isotope Labeling and Biochemical Assessment of Liver-Triacylglycerol in Patients with Different Levels of Histologically-Graded Liver Disease
Syed-Abdul MM, Moore MP, Wheeler AA, Ganga RR, Diaz-Arias A, Petroski GF, Rector RS, Ibdah JA, Parks EJ
The Journal of nutrition 2023
Pharmacologic inhibition of lipogenesis for the treatment of NAFLD
Esler WP, Cohen DE
Journal of Hepatology 2023
Quantitative Determination of De Novo Fatty Acid Synthesis in Brown Adipose Tissue Using Deuterium Oxide.
Turner R, Mukherjee R, Wallace M, Sanchez-Gurmaches J
Journal of visualized experiments : JoVE 2023
Weight-independent effects of Roux-en-Y gastric bypass surgery on remission of nonalcoholic fatty liver disease in mice
Axelrod CL, Langohr I, Dantas WS, Heintz EC, Vandanmagsar B, Yang S, Zunica ER, Leigh Townsend R, Albaugh VL, Berthoud HR, Kirwan JP
Obesity (Silver Spring, Md.) 2023
Establishment of a non‐alcoholic fatty liver disease model by high fat diet in adult zebrafish
Li X, Zhou L, Zheng Y, He T, Guo H, Li J, Zhang J
Animal Models and Experimental Medicine 2023
In-depth analysis of de novo lipogenesis in non-alcoholic fatty liver disease: Mechanism and pharmacological interventions
Zhu Z, Zhang X, Pan Q, Zhang L, Chai J
Liver Research 2023
ER Unfolded Protein Response in Liver In Vivo Is Characterized by Reduced, Not Increased, De Novo Lipogenesis and Cholesterol Synthesis Rates with Uptake of Fatty Acids from Adipose Tissue: Integrated Gene Expression, Translation Rates and Metabolic Fluxes
C Ward, L Peng, S Yuen, M Chang, R Karapetyan, E Nyangau, H Mohammed, H Palacios, N Ziari, L Joe, A Frakes, M Dandan, A Dillin, M Hellerstein
International journal of molecular sciences 2022
Activation of Liver mTORC1 Protects Against NASH via Dual Regulation of VLDL-TAG Secretion and De Novo Lipogenesis
K Uehara, J Sostre-Colón, M Gavin, D Santoleri, K Leonard, R Jacobs, P Titchenell
CMGH Cellular and Molecular Gastroenterology and Hepatology 2022
Farnesoid X Receptor Deficiency Induces Hepatic Lipid and Glucose Metabolism Disorder via Regulation of Pyruvate Dehydrogenase Kinase 4
W Deng, W Fan, T Tang, H Wan, S Zhao, Y Tan, K Oware, J Tan, J Li, S Qu, R Kosuru
Oxidative Medicine & Cellular Longevity 2022
Immune-related pathogenesis and therapeutic strategies of nonalcoholic steatohepatitis
K Chung, Y Cho, S Kim, S Hwang
Archives of Pharmacal Research 2022
Why does obesity cause diabetes?
S Klein, A Gastaldelli, H Yki-Järvinen, P Scherer
Cell Metabolism 2022
Retinoids in the Pathogenesis and Treatment of Liver Diseases
M Melis, X Tang, S Trasino, L Gudas
Nutrients 2022
Insulin Clearance in Obesity and Type 2 Diabetes
H Koh, C Cao, B Mittendorfer
International journal of molecular sciences 2022
Lipogenesis inhibitors: therapeutic opportunities and challenges
B Batchuluun, S Pinkosky, G Steinberg
Nature Reviews Drug Discovery 2022
Added Fructose in Non-Alcoholic Fatty Liver Disease and in Metabolic Syndrome: A Narrative Review
M Coronati, F Baratta, D Pastori, D Ferro, F Angelico, M Ben
Nutrients 2022
Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia
J Borén, M Taskinen, E Björnson, C Packard
Nature Reviews Cardiology 2022
Histone acetyltransferase NAA40 modulates acetyl-CoA levels and lipid synthesis
E Charidemou, M Tsiarli, A Theophanous, V Yilmaz, C Pitsouli, K Strati, J Griffin, A Kirmizis
BMC Biology 2022
Quercetin Reduces Lipid Accumulation in a Cell Model of NAFLD by Inhibiting De Novo Fatty Acid Synthesis through the Acetyl-CoA Carboxylase 1/AMPK/PP2A Axis
A Gnoni, B Stanca, L Giannotti, G Gnoni, L Siculella, F Damiano
International journal of molecular sciences 2022
Abelmoschus esculentus subfractions ameliorate hepatic lipogenesis and lipid uptake via regulating dipeptidyl peptidase-4—With improving insulin resistance
C Peng, Y Ker, H Li, S Tsou, C Lin, C Huang, M Greene
PloS one 2022
Burmese pythons exhibit a transient adaptation to nutrient overload that prevents liver damage
J Magida, Y Tan, C Wall, B Harrison, T Marr, A Peter, C Riquelme, L Leinwand
The Journal of General Physiology 2022
Meta-Inflammation and De Novo Lipogenesis Markers Are Involved in Metabolic Associated Fatty Liver Disease Progression in BTBR ob/ob Mice
L Opazo-Ríos, M Soto-Catalán, I Lázaro, A Sala-Vila, L Jiménez-Castilla, M Orejudo, J Moreno, J Egido, S Mas-Fontao
International journal of molecular sciences 2022
Applications of Quantitative Systems Pharmacology (QSP) in Drug Development for NAFLD and NASH and Its Regulatory Application
S Siler
Pharmaceutical Research 2022
NAFLD: Mechanisms, Treatments, and Biomarkers
Nassir F
Biomolecules 2022
Growth Hormone and Insulin-Like Growth Factor 1 Regulation of Nonalcoholic Fatty Liver Disease
Dichtel LE, Cordoba-Chacon J, Kineman RD
The Journal of clinical endocrinology and metabolism 2022
Non‐alcoholic fatty liver disease and type 2 diabetes: An update
Lee C, Lui DT, Lam KS
Journal of Diabetes Investigation 2022
Interaction effect between NAFLD severity and high carbohydrate diet on gut microbiome alteration and hepatic de novo lipogenesis
Kang H, You HJ, Lee G, Lee SH, Yoo T, Choi M, Joo SK, Park JH, Chang MS, Lee DH, Kim W, Ko G
Gut microbes 2022
Lifestyle Interventions for Non-Obese Patients Both with, and at Risk, of Non-Alcoholic Fatty Liver Disease
Zhang XL, Wang TY, Targher G, Byrne CD, Zheng MH
Diabetes & Metabolism Journal 2022
Adaptation of Oxidative Phosphorylation Machinery Compensates for Hepatic Lipotoxicity in Early Stages of MAFLD
Fahlbusch P, Nikolic A, Hartwig S, Jacob S, Kettel U, Köllmer C, Al-Hasani H, Lehr S, Müller-Wieland D, Knebel B, Kotzka J
International journal of molecular sciences 2022
Extracellular Vesicles in Pathogenesis and Treatment of Metabolic Associated Fatty Liver Disease
Sun J, Zhang D, Li Y
Frontiers in physiology 2022
The Human Milk Oligosaccharide 2′-Fucosyllactose Alleviates Liver Steatosis, ER Stress and Insulin Resistance by Reducing Hepatic Diacylglycerols and Improved Gut Permeability in Obese Ldlr-/-.Leiden Mice
Gart E, Salic K, Morrison MC, Giera M, Attema J, de Ruiter C, Caspers M, Schuren F, Bobeldijk-Pastorova I, Heer M, Qin Y, Kleemann R
Frontiers in Nutrition 2022
Isoschaftoside Reverses Nonalcoholic Fatty Liver Disease via Activating Autophagy In Vivo and In Vitro
Su Y, Kang Y, Yi J, Lin Q, Zhang C, Lin Z, Yan Z, Qu J, Liu J
Evidence-based complementary and alternative medicine : eCAM 2022
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Li M, Chi X, Wang Y, Setrerrahmane S, Xie W, Xu H
Signal Transduction and Targeted Therapy 2022
The association between diabetes and obesity with Dengue infections
Sekaran SD, Liew ZM, Yam HC, Raju CS
Diabetology & metabolic syndrome 2022
Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota
Yang S, Cao S, Li C, Zhang J, Liu C, Qiu F, Kang N
Frontiers in pharmacology 2022
KHK, PNPLA3 and PPAR as Novel Targets for the Anti-Steatotic Action of Bempedoic Acid
Velázquez AM, Bentanachs R, Sala-Vila A, Lázaro I, Rodríguez-Morató J, Sánchez RM, Laguna JC, Roglans N, Alegret M
Biomedicines 2022
Noninvasive NMR/MRS Metabolic Parameters to Evaluate Metabolic Syndrome in Rats
Htun KT, Jaikumkao K, Pan J, Moe Moe AT, Intachai N, Promsan S, Lungkaphin A, Tapanya M, Pasanta D, Tungjai M, Kaewjaeng S, Kim HJ, Kaewkhao J, Lai C, Kothan S
Diagnostics 2022
Editorial: Mitochondrial Biology and Its Role in Metabolic Diseases.
Schneider JG, Tozzo E, Chakravarthy MV
Frontiers in Endocrinology 2022
Rats with high aerobic capacity display enhanced transcriptional adaptability and upregulation of bile acid metabolism in response to an acute high‐fat diet
Stierwalt HD, Morris EM, Maurer A, Apte U, Phillips K, Li T, Meers GM, Koch LG, Britton SL, Graf G, Rector RS, Mercer K, Shankar K, Thyfault JP
Physiological Reports 2022
Redox-Unlockable Nanoparticle-Based MST1 Delivery System to Attenuate Hepatic Steatosis via the AMPK/SREBP-1c Signaling Axis
Li Y, Nie JJ, Yang Y, Li J, Li J, Wu X, Liu X, Chen DF, Yang Z, Xu FJ, Yang Y
ACS Applied Materials & Interfaces 2022
Detangling the interrelations between MAFLD, insulin resistance, and key hormones.
Pal SC, Eslam M, Mendez-Sanchez N
Hormones (Athens, Greece) 2022
Pathogenesis from Inflammation to Cancer in NASH-Derived HCC
Yu S, Wang J, Zheng H, Wang R, Johnson N, Li T, Li P, Lin J, Li Y, Yan J, Zhang Y, Zhu Z, Ding X
Journal of Hepatocellular Carcinoma 2022
Extrahepatic factors in hepatic immune regulation
Zhang S, Lu S, Li Z
Frontiers in immunology 2022
Orosomucoid 2 maintains hepatic lipid homeostasis through suppression of de novo lipogenesis.
Zhou B, Luo Y, Ji N, Hu C, Lu Y
Nature metabolism 2022
Impact of sodium glucose cotransporter-2 inhibitors on liver steatosis/fibrosis/inflammation and redox balance in non-alcoholic fatty liver disease
Bellanti F, Lo Buglio A, Dobrakowski M, Kasperczyk A, Kasperczyk S, Aich P, Singh SP, Serviddio G, Vendemiale G
World Journal of Gastroenterology 2022
Elevated de novo lipogenesis, slow liver triglyceride turnover, and clinical correlations in nonalcoholic steatohepatitis patients
Lawitz EJ, Li KW, Nyangau E, Field TJ, Chuang JC, Billin A, Wang L, Wang Y, Huss RS, Chung C, Subramanian GM, Myers RP, Hellerstein MK
Journal of lipid research 2022
Gypenosides ameliorate high-fat diet-induced non-alcoholic steatohepatitis via farnesoid X receptor activation
Li H, Xi Y, Liu H, Xin X
Frontiers in Nutrition 2022
Update on Non-Alcoholic Fatty Liver Disease-Associated Single Nucleotide Polymorphisms and Their Involvement in Liver Steatosis, Inflammation, and Fibrosis: A Narrative Review
Dwi Astarini F, Ratnasari N, Wasityastuti W
Iranian Biomedical Journal 2022
Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index–related parameters
Xue Y, Xu J, Li M, Gao Y
Frontiers in Endocrinology 2022
Schisantherin A alleviates non-alcoholic fatty liver disease by restoring intestinal barrier function
Yu S, Jiang J, Li Q, Liu X, Wang Z, Yang L, Ding L
Frontiers in Cellular and Infection Microbiology 2022
Association between Mediterranean Diet and Fatty Liver in Women with Overweight and Obesity
Leone A, Bertoli S, Bedogni G, Vignati L, Pellizzari M, Battezzati A
Nutrients 2022
Declining muscle NAD+ in a hyperandrogenism PCOS mouse model: Possible role in metabolic dysregulation
Aflatounian A, Paris VR, Richani D, Edwards MC, Cochran BJ, Ledger WL, Gilchrist RB, Bertoldo MJ, Wu LE, Walters KA
Molecular Metabolism 2022
Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways.
Badmus OO, Hillhouse SA, Anderson CD, Hinds TD, Stec DE
Clinical science (London, England : 1979) 2022
Understanding the extracellular vesicle surface for clinical molecular biology
Hallal S, Tűzesi Á, Grau GE, Buckland ME, Alexander KL
Journal of Extracellular Vesicles 2022
Approaches to Measuring the Activity of Major Lipolytic and Lipogenic Enzymes In Vitro and Ex Vivo
Wilhelm M, Rossmeislová L, Šiklová M
International journal of molecular sciences 2022
Helminth infection and helminth-derived products: A novel therapeutic option for non-alcoholic fatty liver disease
Liu X, Jiang Y, Ye J, Wang X
Frontiers in immunology 2022
Visualization and quantification of de novo lipogenesis using a FASN-2A-GLuc mouse model
Li W, Zhang S, Fu X, Zhang J, Li R, Zhang H, An Q, Wang W, Tian Z, Shi C, Nie Y
Annals of translational medicine 2022
Resveratrol Supplementation in Obese Pregnant Rats Improves Maternal Metabolism and Prevents Increased Placental Oxidative Stress.
Rodríguez-González GL, Vargas-Hernández L, Reyes-Castro LA, Ibáñez CA, Bautista CJ, Lomas-Soria C, Itani N, Estrada-Gutierrez G, Espejel-Nuñez A, Flores-Pliego A, Montoya-Estrada A, Reyes-Muñoz E, Taylor PD, Nathanielsz PW, Zambrano E
2022
Complex regulation of fatty liver disease.
Ginsberg HN, Mani A
Science (New York, N.Y.) 2022
Lactation alters the relationship between liver lipid synthesis and hepatic fat stores in the postpartum period.
Ramos-Roman MA, Syed-Abdul MM, Casey BM, Alger JR, Liu YL, Parks EJ
Journal of lipid research 2022
An integrative approach to assessing effects of a short-term Western diet on gene expression in rat liver
Welles JE, Lacko H, Kawasawa YI, Dennis MD, Jefferson LS, Kimball SR
Frontiers in Endocrinology 2022
The presence of diabetic retinopathy closely associated with the progression of non-alcoholic fatty liver disease: A meta-analysis of observational studies
Zhang GH, Yuan TH, Yue ZS, Wang L, Dou GR
Frontiers in Molecular Biosciences 2022
Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines
Gangopadhyay A, Ibrahim R, Theberge K, May M, Houseknecht KL
Frontiers in neuroscience 2022
Mechanism of action of Orthosiphon stamineus against non-alcoholic fatty liver disease: Insights from systems pharmacology and molecular docking approaches
Alshehade SA, Al Zarzour RH, Murugaiyah V, Lim SY, El-Refae HG, Alshawsh MA
2022
Worksite-based intensive lifestyle therapy has profound cardiometabolic benefits in people with obesity and type 2 diabetes
Yoshino M, Yoshino J, Smith GI, Stein RI, Bittel AJ, Bittel DC, Reeds DN, Sinacore DR, Cade WT, Patterson BW, Cho K, Patti GJ, Mittendorfer B, Klein S
Cell Metabolism 2022
Mechanistic insights into the pleiotropic effects of butyrate as a potential therapeutic agent on NAFLD management: A systematic review
Amiri P, Arefhosseini S, Bakhshimoghaddam F, Jamshidi Gurvan H, Hosseini SA
Frontiers in Nutrition 2022
Protein Targeting to Glycogen (PTG): A Promising Player in Glucose and Lipid Metabolism.
Deng X, Wang C, Xia Y, Yuan G
Biomolecules 2022
Predictive Risk Factors of Nonalcoholic Fatty Liver Disease in a Lean Chinese Population.
Liu L, Shi X, Gao J, Xu C, Liu X
Journal of Personalized Medicine 2022
Trimethylamine N-Oxide Levels in Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Theofilis P, Vordoni A, Kalaitzidis RG
Metabolites 2022
Excessive gluconeogenesis causes the hepatic insulin resistance paradox and its sequelae
Onyango AN
Heliyon 2022
Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles
Martínez\u2010Arranz I, Bruzzone C, Noureddin M, Gil\u2010Redondo R, Mincholé I, Bizkarguenaga M, Arretxe E, Iruarrizaga\u2010Lejarreta M, Fernández\u2010Ramos D, Lopitz\u2010Otsoa F, Mayo R, Embade N, Newberry E, Mittendorf B, Izquierdo\u2010Sánchez L, Smid V, Arnold J, Iruzubieta P, Pérez Castaño Y, Krawczyk M, Marigorta UM, Morrison MC, Kleemann R, Martín\u2010Duce A, Hayardeny L, Vitek L, Bruha R, Aller de la Fuente R, Crespo J, Romero\u2010Gomez M, Banales JM, Arrese M, Cusi K, Bugianesi E, Klein S, Lu SC, Anstee QM, Millet O, Davidson NO, Alonso C, Mato JM
Hepatology 2022
Change in fatty acid composition of plasma triglyceride caused by a 2 week comprehensive risk management for diabetes: A prospective observational study of type 2 diabetes patients with supercritical fluid chromatography/mass spectrometry‐based semi‐target lipidomic analysis
Taya N, Katakami N, Omori K, Hosoe S, Watanabe H, Takahara M, Miyashita K, Nishizawa H, Konya Y, Obara S, Hidaka A, Nakao M, Takahashi M, Izumi Y, Shimomura I, Bamba T
Journal of Diabetes Investigation 2022
Glycohemoglobin: A new warning strategy for non-alcoholic fatty liver disease: Study from the NHANES 2017- 2020
Hou J, Liu Y, Deng Z, Sun J, Zhao M
Frontiers in Endocrinology 2022
Effect of Short-term Vitamin D Supplementation on the Alterations of Glycemic Variables in Response to Exhaustive Eccentric Exercise in Patients with Non-alcoholic Fatty Liver
Rahimpour Z, Hoseini R, Behpour N
Middle East journal of digestive diseases 2022
Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride‐rich lipoprotein metabolism
Deprince A, Hennuyer N, Kooijman S, Pronk AC, Baugé E, Lienard V, Verrijken A, Dirinck E, Vonghia L, Woitrain E, Kloosterhuis NJ, Marez E, Jacquemain P, Wolters JC, Lalloyer F, Eberlé D, Quemener S, Vallez E, Tailleux A, Kouach M, Goossens J, Raverdy V, Derudas B, Kuivenhoven JA, Croyal M, van de Sluis B, Francque S, Pattou F, Rensen PC, Staels B, Haas JT
Hepatology 2022
Eating, diet, and nutrition for the treatment of non-alcoholic fatty liver disease
Semmler G, Datz C, Trauner M
Clinical and Molecular Hepatology 2022
Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study
Harrison SA, Manghi FP, Smith WB, Alpenidze D, Aizenberg D, Klarenbeek N, Chen CY, Zuckerman E, Ravussin E, Charatcharoenwitthaya P, Cheng PN, Katchman H, Klein S, Ben-Ari Z, Mendonza AE, Zhang Y, Martic M, Ma S, Kao S, Tanner S, Pachori A, Badman MK, He Y, Ukomadu C, Sicard E
Nature Medicine 2022
Reprogramming of Hepatic Metabolism and Liver Microenvironment in Nonalcoholic Steatohepatitis
Rui L, Lin JD
Annual Review of Nutrition 2022
The adipocyte supersystem of insulin and cAMP signaling.
Guilherme A, Rowland LA, Wang H, Czech MP
Trends in Cell Biology 2022
Intervention with isoleucine or valine corrects hyperinsulinemia and reduces intrahepatic diacylglycerols, liver steatosis, and inflammation in Ldlr−/−.Leiden mice with manifest obesity‐associated NASH
Gart E, van Duyvenvoorde W, Caspers MP, van Trigt N, Snabel J, Menke A, Keijer J, Salic K, Morrison MC, Kleemann R
The FASEB Journal 2022
Controversies surrounding peripheral cannabinoid-1 receptor in fatty liver disease
Pere Puigserver
Journal of Clinical Investigation 2021
Cannabinoid receptor-1 signaling in hepatocytes and stellate cells does not contribute to NAFLD
Simeng Wang, Qingzhang Zhu, Guosheng Liang, Tania Franks, Magalie Boucher, Kendra K. Bence, Mingjian Lu, Carlos M. Castorena, Shangang Zhao, Joel K. Elmquist, Philipp E. Scherer, Jay D. Horton
Journal of Clinical Investigation 2021
Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease
Catherine C. Cohen, Kelvin W. Li, Adina L. Alazraki, Carine Beysen, Carissa A. Carrier, Rebecca L. Cleeton, Mohamad Dandan, Janet Figueroa, Jack Knight-Scott, Cynthia J. Knott, Kimberly P. Newton, Edna M. Nyangau, Claude B. Sirlin, Patricia A. Ugalde-Nicalo, Jean A. Welsh, Marc K. Hellerstein, Jeffrey B. Schwimmer, Miriam B. Vos
Journal of Clinical Investigation 2021
Roles of Ceramides in Non-Alcoholic Fatty Liver Disease
E Hajduch, F Lachkar, P Ferré, F Foufelle
Journal of Clinical Medicine 2021
The Role and Mechanism of Oxidative Stress and Nuclear Receptors in the Development of NAFLD
T Hong, Y Chen, X Li, Y Lu, J Pu
Oxidative Medicine & Cellular Longevity 2021
Multiple antisense oligonucleotides targeted against monoacylglycerol acyltransferase 1 (Mogat1) improve glucose metabolism independently of Mogat1
AJ Lutkewitte, JM Singer, TM Shew, MR Martino, AM Hall, M He, BN Finck
Molecular Metabolism 2021
Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus
J Yong, JD Johnson, P Arvan, J Han, RJ Kaufman
Nature Reviews Endocrinology 2021
The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights
A Federico, V Rosato, M Masarone, P Torre, M Dallio, M Romeo, M Persico
Nutrients 2021
The interaction between the gut microbiota and dietary carbohydrates in nonalcoholic fatty liver disease
G Park, S Jung, KE Wellen, C Jang
Experimental & molecular medicine 2021
Adaptive and maladaptive roles for ChREBP in the liver and pancreatic islets
LS Katz, S Baumel-Alterzon, DK Scott, MA Herman
The Journal of biological chemistry 2021
Molecular aspects of fructose metabolism and metabolic disease
MA Herman, MJ Birnbaum
Cell Metabolism 2021
Metabolic drivers of non-alcoholic fatty liver disease
KK Bence, MJ Birnbaum
Molecular Metabolism 2021
Role of Insulin Resistance in MAFLD
Y Sakurai, N Kubota, T Yamauchi, T Kadowaki
International journal of molecular sciences 2021
Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
M Masoodi, A Gastaldelli, T Hyötyläinen, E Arretxe, C Alonso, M Gaggini, J Brosnan, QM Anstee, O Millet, P Ortiz, JM Mato, JF Dufour, M Orešič
Nature Reviews Gastroenterology & Hepatology 2021
Mitochondrial oxidative function in NAFLD: Friend or foe?
M Shum, J Ngo, OS Shirihai, M Liesa
Molecular Metabolism 2021
It Is High Time Physicians Thought of Natural Products for Alleviating NAFLD. Is There Sufficient Evidence to Use Them?
G Tarantino, C Balsano, SJ Santini, G Brienza, I Clemente, B Cosimini, G Sinatti
International journal of molecular sciences 2021
Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD
DG Mashek
Molecular Metabolism 2021
Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
K Pafili, M Roden
Molecular Metabolism 2021
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity
H Tilg, TE Adolph, M Dudek, P Knolle
Nature metabolism 2021
Liver macrophages and inflammation in physiology and physiopathology of non‐alcoholic fatty liver disease
R Thibaut, MC Gage, I PinedaTorra, G Chabrier, N Venteclef, F Alzaid
The FEBS journal 2021
Role of 2‑series prostaglandins in the pathogenesis of type 2 diabetes mellitus and non‑alcoholic fatty liver disease (Review)
W Wang, X Zhong, J Guo
International journal of molecular medicine 2021
Brain insulin signalling in metabolic homeostasis and disease
T Scherer, K Sakamoto, C Buettner
Nature Reviews Endocrinology 2021
Measurement of lipogenic flux by deuterium resolved mass spectrometry
X Fu, S Deja, JA Fletcher, NN Anderson, M Mizerska, G Vale, JD Browning, JD Horton, JG McDonald, MA Mitsche, SC Burgess
Nature Communications 2021
A Systems Approach Dissociates Fructose-Induced Liver Triglyceride from Hypertriglyceridemia and Hyperinsulinemia in Male Mice
L Doridot, SA Hannou, SA Krawczyk, W Tong, MS Kim, GS McElroy, AJ Fowler, II Astapova, MA Herman
Nutrients 2021
The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease
A Grefhorst, IP van de Peppel, LE Larsen, JW Jonker, AG Holleboom
Frontiers in Endocrinology 2021
Dietary carbohydrates and fats in nonalcoholic fatty liver disease
H Yki-Järvinen, PK Luukkonen, L Hodson, JB Moore
Nature Reviews Gastroenterology & Hepatology 2021
Sodium Butyrate Supplementation Inhibits Hepatic Steatosis by Stimulating Liver Kinase B1 and Insulin-Induced Gene
ZH Zhao, ZX Wang, D Zhou, Y Han, F Ma, Z Hu, FZ Xin, XL Liu, TY Ren, F Zhang, Y Xue, A Cui, Z Liu, J Bai, Y Liu, G Cai, W Su, X Dai, F Shen, Q Pan, Y Li, JG Fan
CMGH Cellular and Molecular Gastroenterology and Hepatology 2021
Rho-Kinase as a Therapeutic Target for Nonalcoholic Fatty Liver Diseases
I Sousa-Lima, HJ Kim, J Jones, YB Kim
Diabetes & Metabolism Journal 2021
Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus
D Ferguson, BN Finck
Nature Reviews Endocrinology 2021
Cellular Protein Markers, Therapeutics, and Drug Delivery Strategies in the Treatment of Diabetes-Associated Liver Fibrosis
CY Lin, P Adhikary, K Cheng
Advanced Drug Delivery Reviews 2021
The Impact of Macronutrient Intake on Non-alcoholic Fatty Liver Disease (NAFLD): Too Much Fat, Too Much Carbohydrate, or Just Too Many Calories?
T Hydes, U Alam, DJ Cuthbertson
Frontiers in Nutrition 2021
The Troubling Link Between Non-alcoholic Fatty Liver Disease (NAFLD) and Extrahepatic Cancers (EHC)
A Venniyoor, AA Farsi, BA Bahrani
Cureus 2021
The relationships of sex hormone‐binding globulin, total testosterone, androstenedione and free testosterone with metabolic and reproductive features of polycystic ovary syndrome
PI Simons, O Valkenburg, JA Bons, CD Stehouwer, MC Brouwers
2021
Relationship between de novo lipogenesis and serum sex hormone binding globulin in humans
PI Simons, O Valkenburg, I Telgenkamp, KM van der Waaij, DM de Groot, P Veeraiah, JA Bons, MR Taskinen, J Borén, P Schrauwen, JH Rutten, D Cassiman, CG Schalkwijk, CD Stehouwer, VB SchrauwenHinderling, L Hodson, MC Brouwers
Clinical Endocrinology 2021
Nonalcohol fatty liver disease: balancing supply and utilization of triglycerides
LS Santos-Baez, HN Ginsberg
Current Opinion in Lipidology 2021
Metabolic-associated fatty liver disease and lipoprotein metabolism
J Heeren, L Scheja
Molecular Metabolism 2021
Chop / Ddit3 depletion in β cells alleviates ER stress and corrects hepatic steatosis in mice
J Yong, VS Parekh, SM Reilly, J Nayak, Z Chen, C Lebeaupin, I Jang, J Zhang, TP Prakash, H Sun, S Murray, S Guo, JE Ayala, LS Satin, AR Saltiel, RJ Kaufman
Science Translational Medicine 2021
Insulin resistance in cardiovascular disease, uremia, and peritoneal dialysis
M Lambie, M Bonomini, SJ Davies, D Accili, A Arduini, V Zammit
Trends in endocrinology and metabolism: TEM 2021
GH directly inhibits steatosis and liver injury in a sex-dependent and IGF1-independent manner
A Sarmento-Cabral, M del Rio-Moreno, MC Vazquez-Borrego, M Mahmood, E Gutierrez-Casado, N Pelke, G Guzman, PV Subbaiah, J Cordoba-Chacon, S Yakar, RD Kineman
Journal of Endocrinology 2021
Advances in Understanding of the Role of Lipid Metabolism in Aging
KW Chung
Cells 2021
The Role of Notch Signaling Pathway in Non-Alcoholic Fatty Liver Disease
H Xu, L Wang
Frontiers in Molecular Biosciences 2021
Omega-3 mechanism of action in inflammation and endoplasmic reticulum stress in mononuclear cells from overweight non-alcoholic fatty liver disease participants: study protocol for the “Brazilian Omega Study” (BROS)—a randomized controlled trial
ES Batista, T da Silva Rios, VR Muñoz, JS Jesus, MM Vasconcelos, DT da Cunha, JL Marques-Rocha, SC Nakandakari, R Lara, AS da Silva, JR Pauli, ER Ropelle, RA Mekary, LP de Moura, EA Camargo, DE Cintra
Trials 2021
Dietary Macronutrient Composition Differentially Modulates the Remodeling of Mitochondrial Oxidative Metabolism during NAFLD
N Kattapuram, C Zhang, MS Muyyarikkandy, C Surugihalli, V Muralidaran, T Gregory, NE Sunny
Metabolites 2021
Mitochondrial Lipid Homeostasis at the Crossroads of Liver and Heart Diseases
SA Dabravolski, EE Bezsonov, MS Baig, TV Popkova, AN Orekhov
International journal of molecular sciences 2021
Pharmacodynamic effects of direct AMP kinase activation in humans with insulin resistance and non-alcoholic fatty liver disease: A phase 1b study
P Fouqueray, S Bolze, J Dubourg, S Hallakou-Bozec, P Theurey, J Grouin, C Chevalier, P Gluais-Dagorn, D Moller, K Cusi
Cell reports. Medicine 2021
Increased Adipose Tissue Fibrogenesis, Not Impaired Expandability, Is Associated With Nonalcoholic Fatty Liver Disease
JW Beals, GI Smith, M Shankaran, A Fuchs, GG Schweitzer, J Yoshino, T Field, M Matthews, E Nyangau, D Morozov, B Mittendorfer, MK Hellerstein, S Klein
Hepatology 2021
Subcutaneous Adipose Tissue Metabolic Function and Insulin Sensitivity in People With Obesity
HC Koh, S van Vliet, TA Pietka, GA Meyer, B Razani, R Laforest, RJ Gropler, B Mittendorfer
Diabetes 2021
Acetyl-CoA and Metabolite Fluxes Regulate White Adipose Tissue Expansion
JB Felix, AR Cox, SM Hartig
Trends in endocrinology and metabolism: TEM 2021
Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets
DM Tanase, EM Gosav, D Petrov, AE Jucan, CM Lacatusu, M Floria, CC Tarniceriu, CF Costea, M Ciocoiu, C Rezus
Diagnostics 2021
Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and Pancreatitis
P Hernandez, N Passi, T Modarressi, V Kulkarni, M Soni, F Burke, A Bajaj, D Soffer
Current Atherosclerosis Reports 2021
A Review of the Epidemiology, Pathophysiology, and Efficacy of Anti-diabetic Drugs Used in the Treatment of Nonalcoholic Fatty Liver Disease
PP Manka, E Kaya, A Canbay, WK Syn
Digestive Diseases and Sciences 2021
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
M Yoshino, J Yoshino, BD Kayser, GJ Patti, MP Franczyk, KF Mills, M Sindelar, T Pietka, BW Patterson, SI Imai, S Klein
Science 2021
Aquaporins in insulin resistance and diabetes: More than channels!
M Galli, A Hameed, A Żbikowski, P Zabielski
Redox Biology 2021
Gut Microbiome and Metabolites in Patients with NAFLD and after Bariatric Surgery: A Comprehensive Review
J Hoozemans, M de Brauw, M Nieuwdorp, V Gerdes
Metabolites 2021
Lingonberry Improves Non-Alcoholic Fatty Liver Disease by Reducing Hepatic Lipid Accumulation, Oxidative Stress and Inflammatory Response
SM Hewage, S Prashar, K O, YL Siow
Antioxidants 2021
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
M Arrese, JP Arab, F Barrera, B Kaufmann, L Valenti, AE Feldstein
Seminars in liver disease 2021
Effects of Oral Vitamin C Supplementation on Liver Health and Associated Parameters in Patients With Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial
Z He, X Li, H Yang, P Wu, S Wang, D Cao, X Guo, Z Xu, J Gao, W Zhang, X Luo
Frontiers in Nutrition 2021
Amelioration of Hepatic Steatosis in Mice through Bacteroides uniformis CBA7346-Mediated Regulation of High-Fat Diet-Induced Insulin Resistance and Lipogenesis
HB Lee, MH Do, H Jhun, SK Ha, HS Song, SW Roh, WH Chung, YD Nam, HY Park
Nutrients 2021
The influence of nutritional state on the fatty acid composition of circulating lipid fractions: implications for their use as biomarkers of dietary fat intake
SA Parry, F Rosqvist, S Peters, RK Young, T Cornfield, P Dyson, L Hodson
Upsala Journal of Medical Sciences 2021
NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome
A Michelotti, M de Scordilli, L Palmero, M Guardascione, M Masala, R Roncato, L Foltran, E Ongaro, F Puglisi
Cells 2021
Fatty liver index as a predictor for type 2 diabetes in subjects with normoglycemia in a nationwide cohort study
E García-Escobar, S Valdés, F Soriguer, J Vendrell, IM Urrutia-Etxebarria, C Maldonado-Araque, E Ortega, P Ocón, E Montanya, E Menéndez, A Lago-Sampedro, T González-Frutos, R Gomis, A Goday, S García-Serrano, JL Galán-García, C Castell, E Bordiú, R Badía, G Aguilera-Venegas, J Girbés, S Gaztambide, E Delgado, FJ Chaves, L Castaño, A Calle-Pascual, G Rojo-Martínez, J Franch-Nadal
Scientific Reports 2021
Association Between the Triglyceride–Glucose Index and Outcomes of Nonalcoholic Fatty Liver Disease: A Large-Scale Health Management Cohort Study
J Liu, L Guan, M Zhao, Q Li, A Song, L Gao, H Lin, J Zhao
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021
Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota
F Du, R Huang, D Lin, Y Wang, X Yang, X Huang, B Zheng, Z Chen, Y Huang, X Wang, F Chen
Frontiers in microbiology 2021
Triglycerides in Nonalcoholic Fatty Liver Disease: Guilty Until Proven Innocent
I Semova, SB Biddinger
Trends in Pharmacological Sciences 2021
Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit?
G Neokosmidis, E Cholongitas, K Tziomalos
World journal of gastroenterology : WJG 2021
Inhibition of Secretin/Secretin Receptor Axis Ameliorates NAFLD Phenotypes
L Chen, N Wu, L Kennedy, H Francis, L Ceci, T Zhou, N Samala, K Kyritsi, C Wu, A Sybenga, B Ekser, W Dar, C Atkins, V Meadows, S Glaser, G Alpini
Hepatology 2021
Independent associations of thyroid-related hormones with hepatic steatosis and insulin resistance in euthyroid overweight/obese Chinese adults
D Ma, J Zeng, B Huang, F Yan, J Ye, Y Chen, X Zeng, X Zheng, F Xiao, M Lin, C Liu, Z Li
BMC Gastroenterology 2021
Low Screening Rates Despite a High Prevalence of Significant Liver Fibrosis in People with Diabetes from Primary and Secondary Care
LJ Dobbie, M Kassab, AS Davison, P Grace, DJ Cuthbertson, TJ Hydes
Journal of Clinical Medicine 2021
Fatty Acid Synthase Inhibitor Platensimycin Intervenes the Development of Nonalcoholic Fatty Liver Disease in a Mouse Model
M Su, D Cao, Z Wang, Y Duan, Y Huang
Biomedicines 2021
Acute carbohydrate overfeeding: a redox model of insulin action and its impact on metabolic dysfunction in humans
N Istfan, B Hasson, C Apovian, T Meshulam, L Yu, W Anderson, B Corkey
American journal of physiology. Endocrinology and metabolism 2021
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease
P Luukkonen, S Qadri, N Ahlholm, K Porthan, V Männistö, H Sammalkorpi, A Penttilä, A Hakkarainen, T Lehtimäki, M Gaggini, A Gastaldelli, M Ala-Korpela, M Orho-Melander, J Arola, A Juuti, J Pihlajamäki, L Hodson, H Yki-Järvinen
Journal of Hepatology 2021
A guide to understanding endoplasmic reticulum stress in metabolic disorders
Lemmer IL, Willemsen N, Hilal N, Bartelt A
Molecular Metabolism 2021
Influence of adiposity, insulin resistance and intrahepatic triglyceride content on insulin kinetics
Gordon I. Smith, David C. Polidori, Mihoko Yoshino, Monica L. Kearney, Bruce W. Patterson, Bettina Mittendorfer, Samuel Klein
Journal of Clinical Investigation 2020
Decreased adipose tissue oxygenation associates with insulin resistance in people with obesity
Vincenza Cifarelli, Scott Beeman, Gordon I. Smith, Jun Yoshino, Darya Morozov, Joseph W. Beals, Brandon D. Kayser, Jeramie D. Watrous, Mohit Jain, Bruce W. Patterson, Samuel Klein
Journal of Clinical Investigation 2020
Leptin decreases de novo lipogenesis in patients with lipodystrophy
Annah P. Baykal, Elizabeth J. Parks, Robert Shamburek, Majid M. Syed-Abdul, Shaji K. Chacko, Elaine Cochran, Megan Startzell, Ahmed M. Gharib, Ronald Ouwerkerk, Khaled Z. Abd-Elmoniem, Peter J. Walter, Mary Walter, Ranganath Muniyappa, Stephanie T. Chung, Rebecca J. Brown
JCI Insight 2020

Glucocorticoid-Induced Fatty Liver Disease


L Rahimi, A Rajpal, F Ismail-Beigi
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020
Effects of Diet versus Gastric Bypass on Metabolic Function in Diabetes
M Yoshino, BD Kayser, J Yoshino, RI Stein, D Reeds, JC Eagon, SR Eckhouse, JD Watrous, M Jain, R Knight, K Schechtman, BW Patterson, S Klein
New England Journal of Medicine 2020
Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease
KW ter Horst, DF Vatner, D Zhang, GW Cline, MT Ackermans, AJ Nederveen, J Verheij, A Demirkiran, BA van Wagensveld, GM Dallinga-Thie, M Nieuwdorp, JA Romijn, GI Shulman, MJ Serlie
Diabetes care 2020
The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)
DM Tanase, EM Gosav, CF Costea, M Ciocoiu, CM Lacatusu, MA Maranduca, A Ouatu, M Floria
Journal of Diabetes Research 2020
Playing Jekyll and Hyde—The Dual Role of Lipids in Fatty Liver Disease
MR Molenaar, LC Penning, JB Helms
Cells 2020
Perspectives on youth‐onset nonalcoholic fatty liver disease
E CastilloLeon, CE Cioffi, MB Vos
2020
Using total plasma triacylglycerol to assess hepatic de novo lipogenesis as an alternative to VLDL triacylglycerol
L Hodson, SA Parry, T Cornfield, C Charlton, WS Low, CJ Green, F Rosqvist
Upsala Journal of Medical Sciences 2020
Dysregulated lipid metabolism links NAFLD to cardiovascular disease
A Deprince, JT Haas, B Staels
Molecular Metabolism 2020
Organismal Fructose Metabolism in Health and Non-Alcoholic Fatty Liver Disease
S Skenderian, G Park, C Jang
Biology : open access journal 2020
Evolving Role for Pharmacotherapy in NAFLD/NASH
SL Attia, S Softic, M Mouzaki
Clinical and Translational Science 2020
The small intestine shields the liver from fructose-induced steatosis
C Jang, S Wada, S Yang, B Gosis, X Zeng, Z Zhang, Y Shen, G Lee, Z Arany, JD Rabinowitz
Nature metabolism 2020
Dietary protein intake and obesity-associated cardiometabolic function
A Fappi, B Mittendorfer
Current Opinion in Clinical Nutrition and Metabolic Care 2020
Exercise and metabolic health: beyond skeletal muscle
JP Thyfault, A Bergouignan
Diabetologia 2020
Inhibition of fatty acid synthase with FT‐4101 safely reduces hepatic de novo lipogenesis and steatosis in obese subjects with non‐alcoholic fatty liver disease: Results from two early‐phase randomized trials
C Beysen, P Schroeder, E Wu, J Brevard, M Ribadeneira, W Lu, K Dole, T O'Reilly, L Morrow, M Hompesch, MK Hellerstein, K Li, L Johansson, PF Kelly
Diabetes, obesity & metabolism 2020
Atorvastatin promotes AMPK signaling to protect against high fat diet‑induced non‑alcoholic fatty liver in golden hamsters
B Zhang, C Zhang, X Zhang, N Li, Z Dong, G Sun, X Sun
Experimental and therapeutic medicine 2020
Rapamycin-Loaded mPEG-PLGA Nanoparticles Ameliorate Hepatic Steatosis and Liver Injury in Non-alcoholic Fatty Liver Disease
R Zhao, M Zhu, S Zhou, W Feng, H Chen
Frontiers in Chemistry 2020

← Previous 1 2 3 … 13 14 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 2 news outlets
Blogged by 1
Posted by 158 X users
On 2 Facebook pages
On 4 videos
485 readers on Mendeley
See more details